A5101478612- Multiple Sclerosis Research Studies
- Genetic Neurodegenerative Diseases
- Systemic Sclerosis and Related Diseases
- Sleep and Wakefulness Research
- Peripheral Neuropathies and Disorders
- Systemic Lupus Erythematosus Research
- Dermatological and Skeletal Disorders
- Autoimmune and Inflammatory Disorders Research
- Migraine and Headache Studies
- Advanced MRI Techniques and Applications
- Hereditary Neurological Disorders
- Ophthalmology and Eye Disorders
- Acute Lymphoblastic Leukemia research
- Sleep and related disorders
- Neurological disorders and treatments
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Sphingolipid Metabolism and Signaling
- Vestibular and auditory disorders
- Mitochondrial Function and Pathology
- Long-Term Effects of COVID-19
- Neurology and Historical Studies
Fondation Ophtalmologique Adolphe de Rothschild
2025
Sorbonne Université
2006-2021
Assistance Publique – Hôpitaux de Paris
2021
Pitié-Salpêtrière Hospital
2006-2021
Université Paris-Saclay
2021
Centre François Baclesse
2019
Allen Institute for Brain Science
2019
Institut du Cerveau
2019
Background Serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP) have emerged as important biomarkers in multiple sclerosis (MS) aquaporin-4 seropositive neuromyelitis optica spectrum disorder (AQP4-NMOSD). However, their interest myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) remains unclear. Our aim was to characterise sNfL sGFAP profile analyse usefulness predicting relapses disability MOGAD. Methods Retrospective study of adult...
ABSTRACT Introduction Patients diagnosed with optic neuritis (ON) who did not fulfil the diagnostic criteria for multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMO‐SD), tested negative myelin oligodendrocyte glycoprotein immunoglobulin G and which a systemic disease has been excluded are classified as having idiopathic ON (IDON). Methods This was monocentric retrospective observational study. Inclusion were follows: patients IDON, absence of an alternative diagnosis during...
To evaluate sleepiness and central hypersomnia in multiple sclerosis (MS)-associated fatigue, we performed long-term polysomnography patients with MS healthy controls.Patients controls completed questionnaires on sleep, sleepiness, depression. They underwent nocturnal polysomnography, sleep latency tests, bed rest 24-hour polysomnography. Patients were divided into 3 groups (fatigue fatigue no neither nor sleepiness).Among 44 MS, 19 (43.2%) had 15 (34%) only 10 (22.7%) sleepiness. Compared...